CRCL Stock: How One Obesity-Drug Hope Became the World’s Most Traded Mirage
**The Global Circus Spins Around CRCL: When a Tiny Canadian Biotech Becomes the World’s Favorite Punching Bag** By the time the opening bell rang in Toronto, CRCL Therapeutics—market cap roughly the size of a Swiss canton’s annual cheese budget—had already been scalped, eulogized, and resurrected three times on three continents. The stock, best known for…